Filing Details

Accession Number:
0001213900-24-078249
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-12 20:12:24
Reporting Period:
2024-09-09
Accepted Time:
2024-09-12 20:12:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1832511 P3 Health Partners Inc. PIII Services-Health Services (8000) 852992794
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1975600 Cpf Iii-A Pt Spv, Llc 980 North Michigan Avenue
Chicago IL 60611
No No Yes No
1975601 Cpf Iii Pt Spv, Llc 980 North Michigan Avenue,
Suite 1998
Chicago IL 60611
No No Yes No
1975658 Chicago Pacific Founders Ugp Iii, Llc 980 North Michigan Avenue,
Suite 1998
Chicago IL 60611
No No Yes No
1975828 Chicago Pacific Founders Gp Iii, L.p. 980 North Michigan Avenue,
Suite 1998
Chicago IL 60611
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-09-09 80,000 $0.53 76,865,438 No 4 P Indirect See Footnote
Class A Common Stock Acquisiton 2024-09-10 80,000 $0.52 76,945,438 No 4 P Indirect See Footnote
Class A Common Stock Acquisiton 2024-09-11 80,000 $0.56 77,025,438 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.50 to $0.58. The reporting person undertakes to provide P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III -A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III -A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.50 to $0.53. The reporting person undertakes to provide P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.53 to $0.57. The reporting person undertakes to provide P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.